Therefore, 68Ga-Pentixafor imaging could potentially be used to identify adrenocortical carcinoma patients who would benefit from CXCR4-targeted therapies as not all lesions express CXCR4. Here, CXCR4 is linked to adrenal cortex carcinoma.